BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 19660657)

  • 1. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vectors for the treatment of neurodegenerative diseases.
    Martin-Rendon E; Azzouz M; Mazarakis ND
    Curr Opin Mol Ther; 2001 Oct; 3(5):476-81. PubMed ID: 11699892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors for treating and modeling human CNS disorders.
    Azzouz M; Kingsman SM; Mazarakis ND
    J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.
    Dreyer JL
    Methods Mol Biol; 2010; 614():3-35. PubMed ID: 20225033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors: turning a deadly foe into a therapeutic agent.
    Trono D
    Gene Ther; 2000 Jan; 7(1):20-3. PubMed ID: 10680011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
    Gropp M; Reubinoff B
    Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
    de Almeida LP; Zala D; Aebischer P; Déglon N
    Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A; Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviruses in gene therapy clinical research.
    Connolly JB
    Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral-based modelling and correction of neurodegenerative diseases by RNA interference.
    Raoul C; Barker SD; Aebischer P
    Gene Ther; 2006 Mar; 13(6):487-95. PubMed ID: 16319945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-primate lentiviral vectors.
    Poeschla EM
    Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vectors as tools to model and treat neurodegenerative disorders.
    Déglon N; Hantraye P
    J Gene Med; 2005 May; 7(5):530-9. PubMed ID: 15651039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral vectors: are they the future of animal transgenesis?
    Park F
    Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors in clinical trials: Current status.
    D'Costa J; Mansfield SG; Humeau LM
    Curr Opin Mol Ther; 2009 Oct; 11(5):554-64. PubMed ID: 19806504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus vectors: difficulties and hopes before clinical trials.
    Kafri T
    Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.